{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:31:45Z","timestamp":1786509105697,"version":"build-2736575974"},"reference-count":31,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA226363"],"award-info":[{"award-number":["R00CA226363"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R00CA226363"],"award-info":[{"award-number":["R00CA226363"]}],"id":[{"id":"https:\/\/ror.org\/040gcmg81","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"NIMHD","doi-asserted-by":"publisher","award":["1U54MD017979"],"award-info":[{"award-number":["1U54MD017979"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1U54MD017979"],"award-info":[{"award-number":["1U54MD017979"]}],"id":[{"id":"https:\/\/ror.org\/0493hgw16","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation Research and Mentoring Postbaccalaureates Award","doi-asserted-by":"publisher","award":["2318923"],"award-info":[{"award-number":["2318923"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2318923"],"award-info":[{"award-number":["2318923"]}],"id":[{"id":"https:\/\/ror.org\/021nxhr62","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute Temple University Fox Chase Center\/Hunter College Regional Comprehensive Cancer Health Disparity Partnership Award","doi-asserted-by":"publisher","award":["U54CA221704"],"award-info":[{"award-number":["U54CA221704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PSC-CUNY Research Award","award":["ENHC55171"],"award-info":[{"award-number":["ENHC55171"]}]},{"name":"Hunter College"},{"id":[{"id":"https:\/\/ror.org\/00g2xk477","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Oncogenuity, Inc."},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","award":["SPK-03-24"],"award-info":[{"award-number":["SPK-03-24"]}],"id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"award":["SPK-03-24"],"award-info":[{"award-number":["SPK-03-24"]}],"id":[{"id":"https:\/\/ror.org\/01gd7b947","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T34GM149429"],"award-info":[{"award-number":["T34GM149429"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"award":["T34GM149429"],"award-info":[{"award-number":["T34GM149429"]}],"id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"publisher"}]},{"name":"CUNY Transfer to STEM Student Success"},{"name":"Hunter College McNulty Scholars Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Approximately 30% of tumors contain an activating mutation in the oncogene KRAS, leading to increased cell proliferation that often promotes non-small cell lung cancers, colorectal adenocarcinomas, pancreatic ductal adenocarcinomas (PDAC), and other cancers. Among the most common point mutations in KRAS is G12D, an example of an oncogenic sequence present in tumor cells but not normal cells. We developed peptide nucleic acid (PNA) oligomers that selectively bind KRAS G12D sequences and fused them with novel cell-penetrating peptide flanking regions (CPP-PNA-G12D) then evaluated them. Electrophoretic mobility shift assays demonstrated in vitro binding to and selectivity for KRAS G12D over wild-type KRAS and KRAS G12C. Cells and nuclei were able to uptake CPP-PNA-G12D at high efficiency as shown by fluorescent microscopy and flow cytometry. Cell viability assays showed a striking dose-response effect in on-target cells expressing KRAS G12D, while relatively sparing off-target cells expressing KRAS G12C. CPP-PNA-G12D constructs were effective against a panel of PDAC cell lines and in female Balb\/c mice bearing patient-derived xenografts. These results show promise for an enhanced PNA-delivery peptide conjugate strategy as a potential therapeutic strategy to selectively target KRAS mutant cancer cells, with the potential to expand this technology to additional cancer-derived mutant oncogenes.<\/jats:p>","DOI":"10.3390\/ijms27167158","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:10:24Z","timestamp":1786374624000},"page":"7158","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides"],"prefix":"10.3390","volume":"27","author":[{"given":"Jayati","family":"Mondal","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"Yalow Scholars Program, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"Damon Runyon Cancer Research Foundation, Scholars Program for Advancing Research and Knowledge, New York, NY 10006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9329-7224","authenticated-orcid":false,"given":"Dennis","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Hunter College, City University of New York, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Termika O.","family":"Alcindor","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"Maximizing Access to Research Careers Program, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"McNulty Scholars Program, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"Transfer to STEM Student Success Program, Hunter College, City University of New York, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Gerritsen","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"Gerritsen Consulting, San Mateo, CA 94402, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-459X","authenticated-orcid":false,"given":"Tilmann M.","family":"Brotz","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"PharmaDirections, Cary, NC 27513, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Rehlaender","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"PharmaDirections, Cary, NC 27513, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Ross","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"Fortress Biotech, Waltham, MA 02453, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Levy","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"DEL BioPharma, LLC, San Mateo, CA 94402, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Bonagura","sequence":"additional","affiliation":[{"name":"Art Robbins Instruments, Sunnyvale, CA 94089, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Lanzilotta","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"McCormick","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA"},{"name":"National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Rothman","sequence":"additional","affiliation":[{"name":"Oncogenuity, Inc., New York, NY 10014, USA"},{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"},{"name":"Herbert Irving Comprehensive Cancer Center, Department of Medicine, Columbia University School of Medicine, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-716X","authenticated-orcid":false,"given":"Andrew L.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Hunter College, City University of New York, New York, NY 10065, USA"},{"name":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA"},{"name":"Weill Cornell Medicine, Department of Pharmacology, New York, NY 10065, USA"},{"name":"Molecular, Cellular, and Developmental Biology Ph.D. Subprogram, Graduate Center of the City University of New York, New York, NY 10016, USA"},{"name":"Biochemistry Ph.D. Program, Graduate Center of the City University of New York, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/curroncol31040150","article-title":"KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance","volume":"31","author":"Ash","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.trecan.2017.08.006","article-title":"KRAS Alleles: The Devil Is in the Detail","volume":"3","author":"Haigis","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41573-020-0068-6","article-title":"RAS-Targeted Therapies: Is the Undruggable Drugged?","volume":"19","author":"Moore","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1055-9965.EPI-23-0262","article-title":"Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum","volume":"33","author":"Grabski","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/acs.jmedchem.9b02052","article-title":"Identification of the Clinical Development Candidate MRTX849, a Covalent KRAS G12C Inhibitor for the Treatment of Cancer","volume":"63","author":"Fell","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The Clinical KRAS(G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) Inhibitors Allosterically Control GTP Affinity and Effector Interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent Inhibition of Oncogenic and Wild-Type RAS-GTP for Cancer Therapy","volume":"629","author":"Holderfield","year":"2024","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yavin, E. (2020). Peptide Nucleic Acids: Applications in Biomedical Sciences. Molecules, 25.","DOI":"10.3390\/molecules25153317"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1073\/pnas.90.22.10648","article-title":"Strand-Invasion of Duplex DNA by Peptide Nucleic Acid Oligomers","volume":"90","author":"Peffer","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/nar\/23.15.3003","article-title":"Inhibition of NF-\u03baB Specific Transcriptional Activation by PNA Strand Invasion","volume":"23","author":"Vickers","year":"1995","journal-title":"Nucl. Acids Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102086","DOI":"10.1016\/j.omtn.2023.102086","article-title":"Therapeutic and Diagnostic Applications of Antisense Peptide Nucleic Acids","volume":"35","author":"MacLelland","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2009.04975.x","article-title":"Allele-Selective Inhibition of Mutant Huntingtin by Peptide Nucleic Acid-Peptide Conjugates, Locked Nucleic Acid, and Small Interfering RNA","volume":"1175","author":"Hu","year":"2009","journal-title":"Ann. New York Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.02.016","article-title":"Nanoparticle-Mediated Intratumoral Inhibition of miR-21 for Improved Survival in Glioblastoma","volume":"201","author":"Seo","year":"2019","journal-title":"Biomaterials"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/cgt.2017.34","article-title":"Obstruction of BRAFV600E Transcription by Complementary PNA Oligomers as a Means to Inhibit BRAF-Mutant Melanoma Growth","volume":"24","author":"Rothman","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gasparello, J., Papi, C., Zurlo, M., Gambari, L., Manicardi, A., Rozzi, A., Ferrarini, M., Corradini, R., Gambari, R., and Finotti, A. (2022). MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines. Cancers, 15.","DOI":"10.3390\/cancers15010128"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3892\/ol.2022.13250","article-title":"Inhibiting Mutant KRAS G12D Gene Expression Using Novel Peptide Nucleic Acid-based Antisense: A Potential New Drug Candidate for Pancreatic Cancer","volume":"23","author":"Shai","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1907233","DOI":"10.1002\/smll.201907233","article-title":"Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform","volume":"16","author":"Yu","year":"2020","journal-title":"Small"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1063\/1.1730390","article-title":"Theory of the Phase Transition between Helix and Random Coil in Polypeptide Chains","volume":"31","author":"Zimm","year":"1959","journal-title":"J. Chem. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/emboj.2010.7","article-title":"Genetic Analysis of Ras Signalling Pathways in Cell Proliferation, Migration and Survival","volume":"29","author":"Drosten","year":"2010","journal-title":"EMBO J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.21037\/tlcr-23-15","article-title":"Characteristics and Prognostic Analysis of Patients with Detected KRAS Mutations in Resected Lung Adenocarcinomas by Peptide Nucleic Acid-Locked Nucleic Acid Polymerase Chain Reaction (PNA-LNA PCR) Clamp Method","volume":"12","author":"Hashimoto","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(23)00772-9","article-title":"Fruquintinib versus Placebo in Patients with Refractory Metastatic Colorectal Cancer (FRESCO-2): An International, Multicentre, Randomised, Double-Blind, Phase 3 Study","volume":"402","author":"Dasari","year":"2023","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2018.12.007","article-title":"NAPOLI-1 Phase 3 Study of Liposomal Irinotecan in Metastatic Pancreatic Cancer: Final Overall Survival Analysis and Characteristics of Long-Term Survivors","volume":"108","author":"Hubner","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17425255.2019.1620731","article-title":"Pharmacogenetics of Treatments for Pancreatic Cancer","volume":"15","author":"Liu","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e27679","DOI":"10.1016\/j.heliyon.2024.e27679","article-title":"Efficacy and Safety of First-Line Chemotherapies for Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Systematic Review and Network Meta-Analysis","volume":"10","author":"Kang","year":"2024","journal-title":"Heliyon"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"112503","DOI":"10.1016\/j.biopha.2021.112503","article-title":"Clinical Implications of Chemotherapeutic Agent Organ Toxicity on Perioperative Care","volume":"146","author":"Zeien","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcdb.2016.07.012","article-title":"The role of wild type RAS isoforms in cancer","volume":"58","author":"Zhou","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","article-title":"Molecular epidemiology and diagnostics of KRAS mutations in human cancer","volume":"39","author":"Timar","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2017.01.020","article-title":"KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer","volume":"168","author":"Burgess","year":"2017","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s42004-018-0080-5","article-title":"Shape Selective Bifacial Recognition of Double Helical DNA","volume":"1","author":"Thadke","year":"2018","journal-title":"Commun. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:20:57Z","timestamp":1786508457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":31,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167158"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167158","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}